Your browser doesn't support javascript.
loading
Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes.
Numakura, Kazuyuki; Kobayashi, Mizuki; Hatakeyama, Shingo; Naito, Sei; Horikawa, Yohei; Tanaka, Toshikazu; Kamada, Sachiko; Muto, Yumina; Yamamoto, Ryohei; Koizumi, Atsushi; Nara, Taketoshi; Kanda, Sohei; Saito, Mitsuru; Narita, Shintaro; Inoue, Takamitsu; Shimoda, Naotake; Tsuchiya, Norihiko; Ohyama, Chikara; Habuchi, Tomonori.
  • Numakura K; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan. numakura@doc.med.akita-u.ac.jp.
  • Kobayashi M; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Hatakeyama S; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Naito S; Department of Urology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Horikawa Y; Department of Urology, Japanese Red Cross Akita Hospital, Akita, Japan.
  • Tanaka T; Department of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
  • Kamada S; Department of Neurology, Akita University Graduate School of Medicine, Akita, Japan.
  • Muto Y; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Yamamoto R; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Koizumi A; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Nara T; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Kanda S; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Saito M; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Narita S; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Inoue T; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
  • Shimoda N; Department of Urology, Japanese Red Cross Akita Hospital, Akita, Japan.
  • Tsuchiya N; Department of Urology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Ohyama C; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Habuchi T; Department of Urology, Akita University Graduate School of Medicine, Akita, Japan.
Int J Clin Oncol ; 25(8): 1543-1550, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32394047
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Renales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Antineoplásicos Inmunológicos / Nivolumab / Neoplasias Renales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article